QT Imaging Holdings, Inc. - 10-Q Summary (Q3 2025)
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2025. QT Imaging Holdings, Inc. is a medical device company developing and commercializing the QT Breast Scanner, a low-frequency sound wave imaging system. The company operates as a single segment focused on the research, development, and sales of this device. As of the filing date, the company is classified as a smaller reporting company and an emerging growth company.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Revenue | $4,192,101 | $955,970 | $10,649,930 | $4,032,168 |
| Gross Profit | $1,802,673 | $605,303 | $5,441,612 | $2,239,934 |
| Gross Margin | 43.0% | 63.3% | 51.1% | 55.6% |
| Net Loss | $(4,557,406) | $(3,619,494) | $(19,694,921) | $(5,496,958) |
| EPS (Basic & Diluted) | $(0.47) | $(0.51) | $(2.09) | $(1.72) |
| Cash & Restricted Cash | $1,735,400 | $1,564,169 | $1,735,400 | $1,564,169 |
| Total Debt (Current + Long-Term) | $5,295,845 | $5,005,030 | $5,295,845 | $5,005,030 |
| Working Capital Deficit | $(1,454,746) | $(4,877,622) | $(1,454,746) | $(4,877,622) |
Note: Debt figures include current maturities of long-term debt ($5,022,966) and long-term debt ($272,879). Related party notes payable ($3,895,112) are excluded from this specific debt line item but represent significant obligations.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 339% quarter-over-quarter and 164% year-over-year. This was driven by the sale of nine QT Breast Scanners in Q3 2025 compared to two in Q3 2024, fulfilling Minimum Order Quantities (MOQs) under the amended NXC Distribution Agreement.
- Margin Compression: Gross margin decreased to 43.0% in Q3 2025 from 63.3% in Q3 2024 due to variability in the weighted average costs of inventory.
- Operating Expenses: Selling, General, and Administrative (SG&A) expenses increased 25% in Q3 2025 due to higher professional services and employee compensation. However, on a YTD basis, SG&A decreased 34% compared to 2024, primarily due to the absence of significant transaction expenses incurred during the 2024 business combination.
- Non-Cash Expenses: The YTD net loss was significantly impacted by non-cash items, including a $6.6 million loss on the issuance of the Lynrock Lake Term Loan, a $2.1 million debt extinguishment loss, and a $2.1 million increase in the fair value of the earnout liability.
- Debt Restructuring: The company extinguished the Yorkville Note and Cable Car Note in February 2025 using proceeds from a new $10.1 million Lynrock Lake Term Loan. A $5.0 million Tranche B was added in August 2025 and subsequently repaid in October 2025.
Guidance, Outlook, and Risks
- Liquidity Outlook: Management believes cash on hand, proceeds from recent private placements (including an $18.2 million October 2025 PIPE), and expected revenue from distribution agreements will fund operations for at least the next 12 months.
- Revenue Expectations: The Amended NXC Distribution Agreement projects potential cash inflows of up to $18.0 million in 2025 and $27.0 million in 2026. A new Gulf Medical Distribution Agreement in Saudi Arabia targets $11.2 million to $12.3 million in 2026.
- Capital Structure: The company executed a 3:1 reverse stock split effective October 23, 2025, and is seeking to relist on the Nasdaq Capital Market.
- Risks:
- Customer Concentration: 99% of Q3 2025 revenue and 98% of accounts receivable were derived from a single customer (NXC Imaging, Inc.).
- Going Concern: The company has an accumulated deficit of $51.6 million and continues to incur losses. Future profitability depends on scaling revenue to support the cost structure.
- Debt Covenants: The Lynrock Lake Term Loan includes mandatory prepayment provisions based on extraordinary receipts and asset sales, which could constrain liquidity.
Key Facts for Investor Verification
- Customer Dependency: Verify the stability of the relationship with NXC Imaging, which accounts for nearly all current revenue and receivables.
- Debt Obligations: Confirm the terms of the Lynrock Lake Term Loan, specifically the mandatory prepayment triggers and the impact of the recent Tranche B repayment.
- Inventory Valuation: Assess the $5.2 million inventory balance against the declining gross margins to ensure no obsolescence or write-downs are required.
- Reverse Stock Split: Confirm the trading status and volume of the stock post-split on the OTCQB and the progress of the Nasdaq relisting application.
- Earnout Liability: Monitor the $2.51 million earnout liability, which fluctuates based on revenue assumptions and stock price, impacting reported net loss.